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Sun-Induced Nonsynonymous p53 Mutations Are
Extensively Accumulated and Tolerated in Normal
Appearing Human Skin
Patrik L. Sta˚hl1, Henrik Stranneheim1, Anna Asplund2, Lisa Berglund3, Fredrik Ponte´n2
and Joakim Lundeberg1
Here we demonstrate that intermittently sun-exposed human skin contains an extensive number of
phenotypically intact cell compartments bearing missense and nonsense mutations in the p53 tumor
suppressor gene. Deep sequencing of sun-exposed and shielded microdissected skin from mid-life individuals
revealed that persistent p53 mutations had accumulated in 14% of all epidermal cells, with no apparent signs of
a growth advantage of the affected cell compartments. Furthermore, 6% of the mutated epidermal cells
encoded a truncated protein. The abundance of these events, not taking into account intron mutations and
mutations in other genes that also may have functional implications, suggests an extensive tolerance of human
cells to severe genetic alterations caused by UV light, with an estimated annual rate of accumulation ofB35,000
new persistent protein-altering p53 mutations in sun-exposed skin of a human individual.
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INTRODUCTION
An originally proposed structure of human skin is that it is
composed of columnar epidermal proliferative units with
tightly regulated proliferating cells at the basal layer
responsible for constant regeneration of the epidermis
(Potten, 1974; Strachan and Ghadially, 2008) with a turnover
time of 20–60 days (Lindwall et al., 2006). Through
X-chromosome inactivation (Asplund et al., 2001) and
lineage analysis (Jensen et al., 1999) evidence for larger
epidermal units has been found. Depending on approach the
size of the epidermal unit has been estimated to range from
20 cells to several thousand cells (Strachan and Ghadially,
2008). Further clonal expansion of epidermal units is thought
to be mediated by mutant alleles of the p53 gene (Ba¨ckvall
et al., 2005), which have been shown to exert a dominant
negative effect on the wild-type allele, altering the DNA
binding ability of the p53 protein and conferring resistance to
apoptosis (Willis et al., 2004). However, following two
pioneering studies conducted 15 years ago (Jonason et al.,
1996; Ren et al., 1996), the extent to which this effect is
applied in healthy skin has remained largely unexplored
using modern day technology.
Recent studies of human cancers have been able to
penetrate deep into the genomes of the diseases, making
use of massive DNA sequencing to reveal that the multi-
tude of genetic alterations contained in the affected tissues
is enormous (Greenman et al., 2007; Pleasance et al.,
2010a, b). This has stressed the need for proper experimental
design (Parmigiani et al., 2009) as well as has demonstrated
the potential of studying cancer at a whole genome scale
(Stratton et al., 2009). Furthermore, careful analysis of these
events has enabled the characterization of distinct subclonal
events of cancers (Campbell et al., 2008) as well as has
permitted conclusions on the mode of clonal expansion of
tumors (Siegmund et al., 2009).
Preneoplastic tissue at single-cell resolution has been left
largely untouched by similar high-resolution approaches.
Although it provides no phenotypic entry points for sampling,
it is feasible to expect that DNA mutations are present to a
previously undetermined extent even before clonal expansion
occurs (Hanahan andWeinberg, 2000; Pleasance et al., 2010a).
Therefore, one should be able to reveal in much the same
manner, as in cancerous tissue, the morphology as well as the
extent of genetic alteration within the normal counterpart. With
deep-sequencing technology, 2,000 reads per amplicon from a
1,000-cell sample provides approximately single-cell and
single-allelic sequencing resolution. Here we perform such a
massive analysis with high DNA sequence coverage of the
coding exons of the p53 gene, enabling us to determine the
maintained genetic load of sun and UV light exposure in
individual epidermal clones of human skin.
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RESULTS
In the present study, we compared p53 sequences of
epidermal cells from forearm skin that was either permitted
to normal sun-exposure or was shielded from sunlight for
5–10 weeks. Samples from seven subjects were analyzed
through deep sequencing of microdissected epidermal cells,
targeting all the coding exons and a number of intronic
sequences. DNA absorption of UVB radiation generates
dipyrimidine photoproducts through the linkage of adjacent
pyrimidines, resulting in characteristic UV-signature base
changes from C to T, or CC to TT (Brash et al., 1991). We
detected extensive amounts of UV-signature mutations at
dipyrimidine sites in all parts of the p53 locus, both exons
(Figure 1) and introns. We found no significant differences in
the frequency or distribution of the UV-induced mutations
(Supplementary Table S1 online) between shielded and
recently sun-exposed skin.
Irrespective of type, nearly all mutations distinguishable
above background were present in a number of sequences
corresponding to p300 heterozygous cells, within the range
of previous estimates of the size of epidermal units (Jensen
et al., 1999; Asplund et al., 2001). Because these cells could
have come from one or several clones, we will refer to 300
cells as the ‘‘maximum clone size’’. The maximum size is
likely to be the actual size, because a mutation arising
independently several times in one sample would be frequent
enough to appear in different samples; this did not occur.
With the applied shielding and given turnover time of healthy
skin these findings suggest that extensive numbers of
persistent keratinocyte clones with p53 mutations had
accumulated before the study (Figure 2). A total of 195
clones were encountered in 14 samples. Not taking into
account possibly functionally important intron mutations,
p53 coding exon mutations were present in an average of
14% of the epidermal cells in sun-exposed skin of the mid-life
individuals sampled. In skin that had not been previously
exposed to the sun (buttock sample), only one UV-signature
mutation, located in intron 3–4, was distinguishable above
background (Supplementary Table S1 online).
The identified epidermal clones together carried a
randomized pattern of synonymous (33%) and nonsynony-
mous (67%) mutations in their exon sequences (Figure 1),
with a bias for mutations at codon position 1 (Supplementary
Table S1 online). Furthermore, sun-induced intron mutations
occurred at 60% greater frequency (28%) per available
dipyrimidine site than their exon counterparts (17%; Supple-
mentary Table S1 online), indicating a tighter control of
genetic alterations in exons.
No signs of clonal size variation or other apparent
UV-shielding effects were observed when comparing sun-
exposed and recently shielded samples, suggesting that
the clones carrying a p53 mutation each originated from a
single-proliferating cell, remaining from previous years of sun
exposure (Figure 2). Any role of sunlight exposure in clonal
expansion must have occurred in those previous years. In
addition, for the four mutations (all of missense type) present
at the highest frequencies (2.2–9.2%), with the single highest
frequency detected in the only sample in the study with a
double base CC–TT transition (Figure 1), functional amino
acid analysis (Kumar et al., 2009) predicted that those carried
in the four abundant clones were all non-tolerant, i.e. would
lead to an altered function of the encoded protein, in
addition, three of these corresponded to database hot-spot
mutations (Petitjean et al., 2007). The missense mutations
present in the less frequent clones were a mixture of tolerant
and non-tolerant alterations. Importantly, 6% of the non-
synonymous mutations encountered were of nonsense type,
introducing a stop codon, without clear frequency-related
indications of a growth advantage.
DISCUSSION
Our findings indicate that persistent nonsynonymous p53
mutations accumulate in intermittently sun-exposed skin of
Caucasians at high rates, B35,000 per year per individual
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Figure 1. Nonsynonymous mutations across the p53 gene detected in the samples. The lengths of the upper and lower arrow tails indicate the numbers
of nonsynonymous mutations encountered at the marked codons and the frequency of the mutations in the samples, respectively. A mutation present inp1% of
the alleles of the 15,000 cells from each sample is estimated to be present in p300 heterozygous cells. Results of a functional amino acid SIFT analysis
across the gene are illustrated, showing the distribution of tolerant (maintained protein function; green bars, pointing up) and non-tolerant (altered protein
function; red bars, pointing down) amino acid substitutions predicted at each codon.
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(Du Bois and Du Bois, 1916; Weinstein et al., 1984),
implying that 0.24% of all sun-exposed epidermal clonal
units will obtain a new persistent nonsynonymous mutation
per year (Table 1). Further investigations need to be
performed at a genome scale to address the mutation rates
in other genes. But if the random pattern of mutations is true
for all 20,000þ human genes, as it might be if the p53 gene
conferred no growth advantage at any time in the clone’s
growth, an estimation would suggest that over 700 million
nonsynonymous mutations occur on an annual basis in
epidermal clonal units in sun-exposed areas (estimated about
5%; Table 1) of the human body.
We were also able to follow-up previous reports on the
size of epidermal units as determined through lineage studies
(Jensen et al., 1999) and X-chromosome inactivation
(Asplund et al., 2001), and specify the maximum epidermal
clonal unit size to be Bp300 cells, thereby supporting the
proposed view of a morphology with large epidermal cell
compartments. In addition, the multitude of epidermal clones
with p53 mutations suggests that most of the mutations act as
passenger events despite their theoretical implications on
protein function. For the few larger clones, the expansion
could have been promoted in at least three different ways,
through accumulation of driver mutations, through growth of
‘healthy’ epidermal clonal units into an adjacent compart-
ment made available through apoptosis of another epidermal
clonal unit (Zhang et al., 2001), or through an excess of
renewal divisions due to long-term low-intensity UV-irradia-
tion (Klein et al., 2010).
The p53 tumor suppressor protein is a homotetramer
where alleles of the gene carrying nonsynonymous mutations
have been reported to exert a dominant negative effect on its
corresponding wild-type allele in cancers and cell lines,
removing the functionality of the healthy allele through
limiting the ability of the resulting protein to interact with
DNA (Willis et al., 2004). The sensitivity to p53 mutations in
cancer development is also evident in Li Fraumeni patients
with an autosomal dominant inheritance of p53 mutations
(Li et al., 1988). But much like in the patients with this
syndrome, in our samples from healthy skin indications of
the dominant negative effect are not evident, suggesting that
such an effect arises merely from a more extensive
accumulation of nonsynomynous mutations or from a very
specific set of such.
In conclusion, deep sequencing of human skin demon-
strates that sun exposure can cause a significant accumula-
tion of mutations in the genome, at the same time as giving
insight into epidermal morphology. Furthermore, the high
abundance of nonsynonymous mutations in phenotypically
intact epidermal cell compartments suggests that the prevail-
ing view of the dominant negative effect of the p53 gene
should be re-appraised, and that human skin has a substantial
tolerance to mutations traditionally regarded as hazardous.
MATERIALS AND METHODS
Ethics statement
Skin biopsies for the analysis of human keratinocytes were obtained
from the skin of volunteers previously characterized in the study by
Berne and colleagues (Berne et al., 1998). This study was approved
by the local ethics committee and involved 11 healthy volunteers.
The study was conducted according to Declaration of Helsinki
Principles and the participants gave their written informed consent.
Background
During 5–10 weeks of a summer holiday, seven healthy volunteers of
European descent (four female, three male, aged 39–48 years) with
skin types 2 and 3 kept a circular 9mmØ area on one dorsal forearm
constantly covered with a blue denim fabric (SPF 1700) for total
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Figure 2. Proposed schematic view of epidermis. With an epidermal turnover time of 20–60 days, a mutation remaining in denim-protected tissue after this
time period can be considered to be stored in the tissue. If a proliferating cell in the basal layer is afflicted by such a p53 mutation, this mutation will
spread to the entire epidermal clonal unit, making it detectable above background levels when sequencing the p53 gene of the cells in the microdissected tissue
section. Persistent mutations derived from earlier-life sun exposure are detected in both denim-protected and non-protected tissue. In addition, mutations
induced by recent sun exposure will be present in non-protected epidermis; however, they are unable to spread to an entire epidermal clonal unit unless
harbored in a proliferating cell, making it hard to detect them above background levels during sequencing. Epidermal clonal units are sometimes able to
expand into adjacent epidermal clonal units.
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photoprotection (Berne and Fischer, 1980). The fabric was attached
to the skin by a 25mm diameter occlusive dressing (Actiderm,
Convatec, Princeton, NJ). The other forearm served as an untreated
control. A sample from skin not exposed to UV was obtained from
the buttocks of one of the male individuals and was used as a
baseline reference for non-UV-exposed epidermis.
Microdissection and DNA extraction
At 24 hours after the last exposure to sunlight, 3mm punch biopsies
were obtained from denim-protected and control skin of each
volunteer. Biopsies were snap-frozen in liquid nitrogen and stored at
701C. Epidermal cell samples were isolated through laser assisted
microdissection as previously described (Hedrum et al., 1994;
Asplund et al., 2005), obtaining a purity of X99% epidermal cells
as estimated by microscopic inspection during microdissection.
Except for keratinocytes, expected to make up 490% of the cells,
the samples contained fractions of melanocytes and Langerhans
cells, and the presence of a few Merkel cells could not be ruled out.
A total of 10,000–15,000 epidermal cells isolated from each
sample were transferred to tubes containing 20 ml of 1 PCR buffer
(#N808-0243, Perkin Elmer, Waltham, MA), and cells were
subsequently lyzed by incubation at 561C overnight after the addi-
tion of 1.3 mgml1 Proteinase K (Invitrogen, Carlsbad, CA) and 35mM
dichlorodiphenyltrichloroethane (Sigma, St Louis, MO). Proteinase K
was then heat-inactivated at 951C for 15min.
Primer design
A total of 12 pairs of fusion primers targeting the coding exons 2–11
of the p53 gene (Supplementary Table S2 online) were designed
using in-house software and ordered to be synthesized (Thermo
Fisher Scientific, Waltham, MA). A total of four sets of primer pairs
were constructed, each carrying one out of four unique tags (no tag,
TA, AC, CG).
Targeted exon amplification
For each of the 15 extracted DNA samples, at total of 12 PCR
reaction mixtures were prepared using one of the tagged primer sets
described above, each with a total volume of 50 ml and containing
5ml FastStart High Fidelity Reaction Buffer (10 with 18mM MgCl2;
Roche, Basel, Switzerland), 5ml deoxynucleotide triphosphates
(2mM), 1ml FastStart High Fidelity Enzyme Blend (5U ml1; Roche),
1ml of each primer (10mM), 4ml extracted DNA, and water. PCR
reactions were cleaned using SPRI beads (Invitrogen, Carlsbad, CA)
according to manufacturer’s instructions, and quantitated by
fluorometry.
Sample pooling and sequencing
The tagged samples were mixed in equimolar proportions in four
different pools and then sequenced in forward and reverse
directions, using one large region of a large picotiterplate (70 75
PTP, 454/Roche) for each pool in a total of two runs on a Genome
Sequencer FLX (454/Roche), using standard chemistry for long read-
lengths (LR70, 454/Roche).
Data analysis
Acquired data were analyzed against UCSC hg 18 using the
Amplicon Variant Analysis software (454/Roche), including filters
based on sequencing depth, individual base quality scoring, and the
specifically inherent error rates of the 454 massively parallel
pyrosequencing method at different positions in the target sequence,
to find high-confidence variants detected in both forward and
reverse reads. To verify the results of the Amplicon Variant Analysis
software a next-generation sequencing adapted Bloom filtering
application (Stranneheim et al., 2010) was used to view low-
frequency variants and the level of background noise from PCR and
sequencing errors. On average, an excess of 2,000 reads covered
every amplicon and variant, thereby covering every allele in the
sequenced sample (Supplementary Table S3 online). Following the
analyses, variants with UVB-characteristic C–T, CC–TT, G–A, or
GG–AA mutations at dipyrimidine sites, with a forward and reverse
consensus frequency of at least 0.4 percent were selected for
downstream analysis and interpretation. The SIFT algorithm (Kumar
et al., 2009) was used for functional amino acid analysis of missense
mutations. The IARC TP53 database (v. R13) was searched for hot
spot codons for skin tumors (Petitjean et al., 2007).
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Table 1. p53 Nonsynonymous mutations in epidermal
clonal units accumulated per year in intermittently
chronically sun-exposed areas1
I. Total nonsynonymous mutations encountered 64
II. Total number of individuals 7
III. Nonsynonymous mutations per individual
(total 2 samples; mean 25,000 cells)
9.14
IV. Nonsynonymous mutations per individual per year
(mean age 44 years)
0.21
V. Total body area (m2) calculated using the Du Bois
formula (body height 180 cm, weight 75 kg)
1.94
VI. Intermittently chronically sun-exposed body area (m2)
(face, forearms, V-chest area), est. 5% of total
0.1
VII. Estimated epidermal cells per 1m2 skin2 4.40E+10
VIII. Estimated novel p53 mutations in epidermal
clonal units in VI per individual per year;
(VII* VI/25,000 cells)* IV
3
35,511
IX. Estimated number of epidermal clonal units in VI
(300 cell ECU); (VII* VI/300)
1.50E+07
X. Fraction of p53 mutated epidermal clonal
units in VI per year4
0.24%
Abbreviation: ECU, epidermal clonal unit.
1Rate of accumulation of p53 nonsynonymous mutations in epidermal
clonal units.
24.4E+10 cells per m2 skin (Du Bois and Du Bois, 1916; Weinstein et al.,
1984).
3Briefly, to calculate the number of new p53 mutations in epidermal clonal
units in intermittently chronically sun-exposed skin per individual per
year, the number of persistent p53 mutations in our samples (25,000 cells
per individual) was extrapolated to correlate with the number of
epidermal cells in the affected body areas.
4Given the estimated size of an epidermal clonal unit of 300 cells, the
fraction of p53 mutated epidermal clonal units per individual per year out
of all epidermal clonal units in the affected areas was calculated.
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